• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本免疫球蛋白A肾病的自然病史及危险因素。进行性肾病研究组。

Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.

作者信息

Koyama A, Igarashi M, Kobayashi M

机构信息

Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.

出版信息

Am J Kidney Dis. 1997 Apr;29(4):526-32. doi: 10.1016/s0272-6386(97)90333-4.

DOI:10.1016/s0272-6386(97)90333-4
PMID:9100040
Abstract

The Research Group on Progressive Renal Diseases conducted a national survey, in Japan, of cases of primary glomerulonephritis (GN) in 1985 and 1993. The results of the survey, reported here, revealed a high prevalence and relatively poor prognosis for immunoglobulin A nephropathy (IgAN). Using immunofluorescent microscopy, 47.2% of 1,063 patients were diagnosed as having IgAN; 62.8% of patients had diffuse mesangial proliferative GN, and focal mesangial proliferative GN was observed in 23.0%. Nearly 70% of the patients had no clinical symptoms, and the IgAN was detected by routine physical examination. The mean period of observation was 11.8 +/- 6.3 years. Renal survival rates for the 502 cases of IgAN, in which the start of dialysis and renal-related death were end points, were 96%, 85%, 75%, and 61% at 5, 10, 15, and 20 years, respectively, from the time of the detection of the earliest known renal abnormalities. Renal survival rates of patients with diffuse mesangial proliferative GN were 96%, 83%, 75%, and 59% at 5, 10, 15, and 20 years, respectively. At the end of the observation period, 20% of patients had improved, 45.8% showed no change, 13.5% had deteriorated, and 20.4% had renal-related death. The risk factors for renal failure by logistic multivariate analysis were serum creatinine concentration > or =1.4 mg/dL (relative risk, 3.5) and levels of urinary protein > or = +(dipstick) (relative risk, 6.4), determined at the time of biopsy. These parameters can be useful for assessing prognosis during the relatively advanced stages of this disease. It is important to note that a relatively high percentage of patients with IgAN progressed to end-stage renal failure even when their histologic findings comprised only minor glomerular abnormalities or focal proliferative changes.

摘要

进行性肾病研究小组于1985年和1993年在日本对原发性肾小球肾炎(GN)病例进行了全国性调查。本文报道的调查结果显示,免疫球蛋白A肾病(IgAN)的患病率较高且预后相对较差。采用免疫荧光显微镜检查,1063例患者中有47.2%被诊断为IgAN;62.8%的患者患有弥漫性系膜增生性GN,23.0%观察到局灶性系膜增生性GN。近70%的患者无临床症状,IgAN通过常规体检被发现。平均观察期为11.8±6.3年。以开始透析和与肾相关的死亡为终点,502例IgAN患者从最早已知的肾脏异常被检测出时起,5年、10年、15年和20年的肾脏存活率分别为96%、85%、75%和61%。弥漫性系膜增生性GN患者的肾脏存活率在5年、10年、15年和20年分别为96%、83%、75%和59%。在观察期末,20%的患者病情好转,45.8%无变化,13.5%病情恶化,20.4%发生与肾相关的死亡。经逻辑多变量分析,活检时血清肌酐浓度≥1.4mg/dL(相对风险,3.5)和尿蛋白水平≥ +(试纸法)(相对风险,6.4)是肾衰竭的危险因素。这些参数可用于评估该疾病相对晚期的预后。需要注意的是,即使IgAN患者的组织学表现仅为轻微的肾小球异常或局灶性增生性改变,仍有相当比例的患者进展至终末期肾衰竭。

相似文献

1
Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.日本免疫球蛋白A肾病的自然病史及危险因素。进行性肾病研究组。
Am J Kidney Dis. 1997 Apr;29(4):526-32. doi: 10.1016/s0272-6386(97)90333-4.
2
Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.IgA肾病的组织学亚分类:244例临床病理研究
Am J Kidney Dis. 1997 Jun;29(6):829-42. doi: 10.1016/s0272-6386(97)90456-x.
3
Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Research Group on Progressive Chronic Renal Disease.日本原发性肾小球肾炎的全国性长期调查:1850例活检病例观察。进行性慢性肾病研究组
Nephron. 1999;82(3):205-13. doi: 10.1159/000045404.
4
Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.免疫球蛋白A肾病的自然病程及预后预测因素:中国204例患者的长期随访
Nephrology (Carlton). 2008 Jun;13(3):242-6. doi: 10.1111/j.1440-1797.2007.00898.x. Epub 2008 Jan 23.
5
A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.IgA 肾病的组织学分类对预测长期预后的价值:重点是终末期肾病。
J Nephrol. 2013 Mar-Apr;26(2):350-7. doi: 10.5301/jn.5000151. Epub 2012 Jun 7.
6
Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.血清免疫球蛋白 G 可早期预测免疫球蛋白 A 肾病的风险。
Int Immunopharmacol. 2019 Jan;66:13-18. doi: 10.1016/j.intimp.2018.10.044. Epub 2018 Nov 9.
7
Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan.采用日本新提出的缓解标准评估儿童IgA肾病的长期发病率。
Clin Exp Nephrol. 2015 Dec;19(6):1149-56. doi: 10.1007/s10157-015-1105-3. Epub 2015 Mar 24.
8
IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes.儿童和成人IgA肾病:组织学特征与临床结局的比较
Nephrol Dial Transplant. 2008 Aug;23(8):2537-45. doi: 10.1093/ndt/gfn014. Epub 2008 Feb 10.
9
IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.IgA肾病:终末期肾衰竭的预后分类。东部肾脏病学家协会
Nephrol Dial Transplant. 1997 Dec;12(12):2569-75. doi: 10.1093/ndt/12.12.2569.
10
Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.扁桃体切除术可延缓 IgA 肾病进展为终末期肾病。
Ren Fail. 2012;34(4):448-53. doi: 10.3109/0886022X.2011.653775. Epub 2012 Jan 20.

引用本文的文献

1
species on the tonsillar surface predicts favorable clinical outcomes in patients with Immunoglobulin A nephropathy who underwent tonsillectomy.扁桃体表面的菌种可预测接受扁桃体切除术的IgA肾病患者的良好临床结局。
Ren Fail. 2025 Dec;47(1):2550617. doi: 10.1080/0886022X.2025.2550617. Epub 2025 Sep 3.
2
Association between tonsillectomy plus steroid pulse therapy and renal outcomes in patients with IgA nephropathy: a retrospective cohort study.扁桃体切除术加类固醇脉冲疗法与IgA肾病患者肾脏预后的关联:一项回顾性队列研究
BMC Nephrol. 2025 Aug 23;26(1):484. doi: 10.1186/s12882-025-04408-5.
3
Pretreatment GFR Slopes Predict Dapagliflozin Response in IgA Nephropathy.
治疗前肾小球滤过率斜率可预测达格列净在IgA肾病中的疗效。
Kidney Int Rep. 2025 Apr 30;10(7):2405-2413. doi: 10.1016/j.ekir.2025.04.042. eCollection 2025 Jul.
4
Characterisation of IgA Nephropathy in an Australian Cohort.澳大利亚队列中IgA肾病的特征分析
Int J Nephrol. 2025 Mar 27;2025:9976879. doi: 10.1155/ijne/9976879. eCollection 2025.
5
Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.利用计算机化医疗计费数据库,基于机器学习识别IgA肾病患者。
PLoS One. 2024 Dec 5;19(12):e0312915. doi: 10.1371/journal.pone.0312915. eCollection 2024.
6
The proteinuria selectivity index value predicts the remission of IgA nephropathy: a retrospective cohort study.蛋白尿选择性指数值可预测 IgA 肾病的缓解:一项回顾性队列研究。
Ren Fail. 2024 Dec;46(2):2423839. doi: 10.1080/0886022X.2024.2423839. Epub 2024 Nov 4.
7
Safety and efficacy assessment of fecal microbiota transplantation as an adjunctive treatment for IgA nephropathy: an exploratory clinical trial.粪便微生物群移植作为IgA肾病辅助治疗的安全性和疗效评估:一项探索性临床试验
Sci Rep. 2024 Oct 2;14(1):22935. doi: 10.1038/s41598-024-74171-4.
8
IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis.国际小儿肾脏病协会(IPNA)关于IgA肾病和IgA血管炎肾炎患儿诊断与管理的临床实践建议。
Pediatr Nephrol. 2025 Feb;40(2):533-569. doi: 10.1007/s00467-024-06502-6. Epub 2024 Sep 27.
9
Contribution of collagen-binding protein Cnm of Streptococcus mutans to induced IgA nephropathy-like nephritis in rats.变形链球菌胶原结合蛋白 Cnm 对大鼠诱导 IgA 肾病样肾炎的作用。
Commun Biol. 2024 Sep 14;7(1):1141. doi: 10.1038/s42003-024-06826-x.
10
A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study.扁桃体切除术联合类固醇冲击疗法与单纯扁桃体切除术治疗免疫球蛋白A肾病患者的临床疗效比较:一项回顾性观察研究。
Clin Exp Nephrol. 2024 Dec;28(12):1254-1260. doi: 10.1007/s10157-024-02527-1. Epub 2024 Jun 18.